Blake P. Moore
Impact in
-
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
-
- Virus-based gene therapy research
- Glioma Diagnosis and Treatment
Papers in
-
- Respiratory viral infections research 5
- Herpesvirus Infections and Treatments 3
- Cytomegalovirus and herpesvirus research 3
- Genetics 6
- Virus-based gene therapy research 6
- Co-authors
- Gregory K. Friedman (8 shared papers)Elizabeth A. Beierle (7 shared papers)Douglas R. Hurst (3 shared papers)Li Nan (6 shared papers)Rajeev S. Samant (3 shared papers)Danny R. Welch (3 shared papers)G. Yancey Gillespie (5 shared papers)James M. Markert (5 shared papers)
- Journals
- Scientific Reports (2 papers)Neuro-Oncology (2 papers)Biochemical and Biophysical Research Communications (1 paper)Gene Therapy (1 paper)Molecular Therapy — Oncolytics (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Blake P. Moore
19 papers receiving 429 citations
Peers
Comparison fields: 5 of 45
- Oncology 146
- Genetics 131
- Genetics 39
- Pathology and Forensic Medicine 63
- Molecular Biology 238
Countries citing papers authored by Blake P. Moore
This map shows the geographic impact of Blake P. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blake P. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blake P. Moore more than expected).
Fields of papers citing papers by Blake P. Moore
This network shows the impact of papers produced by Blake P. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blake P. Moore. The network helps show where Blake P. Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside Blake P. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 66 | |
| 2 | 2006 | 62 | |
| 3 | 2008 | 61 | |
| 4 | 2015 | 56 | |
| 5 | 2014 | 29 | |
| 6 | 2005 | 25 | |
| 7 | 2018 | 23 | |
| 8 | 2017 | 20 | |
| 9 | 2013 | 16 | |
| 10 | 2012 | 15 | |
| 11 | 2010 | 14 | |
| 12 | 2010 | 14 | |
| 13 | 2018 | 11 | |
| 14 | 2019 | 4 | |
| 15 | 2015 | 4 | |
| 16 | A Cell Based HTS Approach for the Discovery of New Inhibitors of RSV | 2013 | 4 |
| 17 | Identification of a Series of Quinazolinediones as Potent, Selective, Post-Entry Inhibitors of Human Respiratory Syncytial Virus ( h RSV) via a Cell-Based High Throughput Screen and Chemical Optimization | 2013 | 4 |
| 18 | 2016 | 3 | |
| 19 | A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus | 2010 | 1 |
About Blake P. Moore
Blake P. Moore is a scholar working on Epidemiology, Genetics, Molecular Biology, Infectious Diseases and Organic Chemistry, having authored 19 papers that have together received 432 indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), Respiratory viral infections research (5 papers), Mechanisms of cancer metastasis (3 papers), Herpesvirus Infections and Treatments (3 papers), Cytomegalovirus and herpesvirus research (3 papers), Cancer Mechanisms and Therapy (2 papers), Mosquito-borne diseases and control (2 papers) and Malaria Research and Control (2 papers). The work is most often cited by research in Oncology (146 citations), Genetics (131 citations), Genetics (39 citations), Pathology and Forensic Medicine (63 citations) and Molecular Biology (238 citations). Blake P. Moore has collaborated with scholars based in United States and Canada. Frequent co-authors include Gregory K. Friedman, Elizabeth A. Beierle, Douglas R. Hurst, Li Nan, Rajeev S. Samant, Danny R. Welch, G. Yancey Gillespie, James M. Markert, Xiaosi Han and Catherine P. Langford. Their work appears in journals such as Scientific Reports, Neuro-Oncology, Biochemical and Biophysical Research Communications, Gene Therapy and Molecular Therapy — Oncolytics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.